The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice
Alex Broom(The University of Sydney), Mustafa Khasraw(Northwestern University), Katherine Kenny(The University of Sydney), Carey K. Anders(Duke University), Imogen Harper(The University of Sydney), Michelle Peterie(The University of Sydney), Jennifer Durling(Duke Medical Center), Brent A. Hanks(Duke University), Alexander Page(James Cook University), Margaret Johnson, Nicole Cort(Duke Medical Center), Eric Lipp(Duke Medical Center), Kyle M. Walsh(Yale University), David M. Ashley(Unknown), Aaron C. Tan(Baker Heart and Diabetes Institute), Leah Williams Veazey(The University of Sydney), Amanda E.D. Van Swearingen(Duke Cancer Institute)
Cited by 11
Related Papers
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
|Clinical Breast Cancer|2009|644